Growth Stage

Change How the World Prevents, Detects, And Treats Type 2 Diabetes

Change How the World Prevents, Detects, And Treats Type 2 Diabetes


Raised this Round: Raised: $358,639

Total Commitments ($USD)


Texture Capital

Start Date


Close Date

Not Provided

Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common


Series B

SEC Filing Type

RegA+    Open SEC Filing

Price Per Share


Pre-Money Valuation


Year Founded



Healthcare & Pharmaceuticals

Tech Sector


Distribution Model




Capital Intensity



Dauphin, Manitoba

Business Type


Scimar is raising funds on Texture Capital through Reg A+ crowdfunding. The company discovered the hepatalin hormone and is revolutionizing the prevention, diagnosis, and treatment of type 2 diabetes. Scimar is developing medical interventions based on the science of hepatalin to handle excess glucose in the body and bring an end to type 2 diabetes. The company has currently conceived four products, including SciMar NuPa Test, SciMar NuPa Daily, SciMar NuPa Renew, and Hepatalin-S, and plans to grow more. Dr. W. Wayne Lautt and Mick Lautt founded Scimar in 2009. The current crowdfunding campaign has a maximum target of $55 million. The campaign proceeds will be used for research and development, expanded infrastructure, cost of capital, facilities, operations, brand building, and accounting expenses.

Balance Sheet

Cash and Cash Equivalents


Investment Securities


Accounts and Notes Receivable


Property, Plant and Equipment (PP&E)


Property and Equipment


Total Assets


Accounts Payable & Accrued Liabilities


Long Term Debt


Total Liabilities


Total Stockholders' Equity


Total Liabilities and Equity


Statement of Comprehensive Income Information

Total Revenues


Costs & Expenses Applicable to Rev


Depreciation and Amortization


Net Income


Earnings Per Share - Basic


Earnings Per Share - Diluted


Auditor: KPMG
Financials as of: 12/20/2023
Create a free account today to gain access to Kingscrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings Kingscrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Scimar on Texture Capital 2024
Platform: Texture Capital
Security Type: Equity - Common
Valuation: $478,866,592
Price per Share: $5.50

Follow company

Follow Scimar on Texture Capital 2024

Buy Scimar's Deal Report

Warning: according to the close date for this deal, Scimar may no longer be accepting investments.

Scimar Deal Report

Get Kingscrowd's comprehensive report on Scimar including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Scimar is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Scimar deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge